Fatin Nur Majdina Nordin is a senior lecturer in the Programme of Applied Science with Islamic Studies at the Academy of Islamic Studies, Universiti Malaya. Her academic work focuses on integrating scientific knowledge with Islamic principles, particularly in the areas of hygiene, health, and halal science. She holds a Bachelor's degree in Applied Science with Islamic Studies (BAScIStud) majoring in Biohealth Science, and a Master of Philosophy (MPhil) in Medicine (Dentistry and Islamic Studies), where she examined the use of Salvadora persica (miswak) in oral health care. She later pursued a PhD in Science, Technology, and Health, focusing on cosmetic safety, where she explored the risks of cosmetic ingredients and the effectiveness of product labels in communicating ingredient risks. Her research interests include health and well-being, halal science, hygiene and environmental health, knowledge integration, and the role of women in Islam. In addition to her academic contributions, she is involved in initiatives related to mental hygiene awareness, environmental sustainability, and women's empowerment within the framework of Islamic principles. Her work aims to contribute to a more comprehensive understanding of science and its applications within an Islamic context, fostering interdisciplinary research and education.  

Dr. Leong research focus on investigating the mechanism of action of potent compounds toward developing new anticancer and antidiabetes drugs. His research adopts an in vitro approach using cell-based and enzymatic assays to identify the various cellular pathways modulated by a potent compound. The research outcome is to understand the mechanism of action of the compound, a prerequisite requirement in developing a new drug entity. In addition, he employs metabolomics to evaluate biomarkers in explaining the treatment outcomes or disease progression. International collaboration has geared his research towards cancer stem cells and utilizing zebrafish as an animal model for cancer. It is believed that cancer stem cells is a subset of cells in tumour that drives chemoresistance and relapse in cancer patients. Therefore, strategies to develop new chemotherapy against the subset of cells is of great interest to tackle the problem.